What We Do
The mission of AID at Michigan State University (MSU) is to build a collaboration of AI, big data and the local drug discovery community, train the next generation of scientists with specialized expertise, and ultimately evolve into a sustainable research and education program. To achieve research excellence, AID leverages emerging big data (e.g., single cell and spatial transcriptomics, electronic health records), state-of-the-art AI methods (e.g., graph neural network, transfer learning, deep reinforcement learning), and advanced preclinical models (e.g., ex vivo tissue slice culture, organoids). AID takes a novel, previously unexplored patient-centric approach where drugs are proposed based on the RNA features derived from patients and are subsequently validated in the models derived from patient tissues. AID supports the repurposing of existing drugs for new indications in order to expedite the discovery and approval process, as well as the discovery of novel compounds, which may take more time but offer new therapeutic approaches and intellectual property. One key competency for AID is its unique transcriptomics-based drug discovery platform developed by our team members.
